Plant-Derived Anti-TMV Metabolites: Mechanisms, Limitations and Future Perspectives

Muhammad Qasim Aslam1,2, Ziran Gao1,3, Amr Said Mohamed1,4

  • 1Biotechnology and Germplasm Resources Institute, Yunnan Academy of Agricultural Sciences/Yunnan Provincial Key Laboratory of Agricultural Biotechnology/Key Lab of Southwestern Crop Gene Resource and Germplasm Innovation, Ministry of Agriculture and Rural Affairs, Kunming 605205, China.

Viruses
|July 28, 2026
PubMed
Summary

Plant metabolites offer eco-friendly solutions against Tobacco mosaic virus (TMV). This review details how these compounds, including alkaloids and flavonoids, target TMV directly or boost plant immunity for sustainable crop protection.

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.